CBR Research Grants

Project Summaries—2005

Quick Links:

2007

2006

2005

2004

2003

2002

2001

2000

1999

1998

1997

1996

1995


2005

Surface -Engineered Implantable Materials for Hernia Repair
Maria Santore, Ph.D., Polymer Science and Engineering, UMass Amherst
David Earle, M.D., Director of Minimally Invasive Surgery, Baystate Medical Center

This program will develop an implantable biomaterial for hernia repair whose surface properties elicit appropriate physiological responses:  Long term adhesion to and / or ingrowth of abdominal wall connective tissue on some areas and bio-inertness (lack of adhesion, ingrowth, or immunoreaction) on others.  This will be achieved by surface modification of polypropylene, a material already used for hernia repair:  Its mechanical properties work well in the abdomen, but its native surface properties often cause complications. The strategy for bio-inert regions of the implant will be to develop robust polyethylene oxide (PEO) brushes.  While PEO-surfaces often work well in-vitro in on model surfaces, both in-vitro and in-vivo studies indicate medium to poor performance with PEO treatments on “real” implantable materials.  Brush-covered micron-sized vesicles, however, are biocompatible in rats. The proposed work therefore hypothesizes that the prior problems with PEO layers on “real” surfaces stemmed from inadequate “brush” formation, and the study will go forward to develop chemistries appropriate to polypropylene that will produce brushes that are truly bio-resistant.  Separately for surfaces designed to promote tissue ingrowth, the study will compare hydrophobic adhesive surfaces to those that are collagen-coated.  The proposed work will be carried out jointly in the Santore lab at UMass and in the animal (swine) facility at Baystate under the supervision of Dr. Earle.  While PEO-surfaces have been a topic of fundamental study, this work will be their first use for hernia-repair materials.

Effective date: September 1, 2005

Male Factor in Infertile Couples: a Molecular Approach
Pablo E. Visconte Ph.D.; Rafael Fissore, DVM Ph.D.; Veterinary and Animal Science UMass Amherst
Daniel Grow M.D.; Margaret Arny Ph.D.; Teru Jellerette Ph.D.; Baystate Medical Center

Mammalian sperm are not able to fertilize eggs immediately after ejaculation. They acquire fertilization capacity after residing in the female tract for a finite period of time. The physiological changes occurring in the female reproductive tract rendering the sperm able to fertilize constitute the phenomenon of " sperm capacitation ". Using the mouse as an experimental model, it has been demonstrated that capacitation is associated with an increase in the tyrosine (tyr) phosphorylation of a subset of proteins. The presence of this regulatory pathway has subsequently been demonstrated in sperm from other species including human. After capacitation, sperm are ready to fertilize the egg; during fertilization, the sperm induces in the egg a series of changes in intracellular calcium concentration ([Ca 2+ ]i), [Ca 2+ ]i oscillations , that initiate egg activation. Although the precise mechanism by which the sperm initiates these oscillations is not known, there is evidence suggesting that the sperm may deliver, after fusion, a factor(s) into the egg cytosol that is responsible for triggering Ca 2+ release. This factor from the sperm appears to mediate Ca 2+ release by persistently activating the phosphoinositide (PI) pathway and is believed to be phospholipase C z (PLC z), a novel sperm-specific PLC.

Despite these advances in understanding the molecular mechanisms regulating phosphorylation during capacitation and the triggering of Ca 2+ oscillations, little is known about the clinical correlates of these discoveries. While 85 % of couples can conceive after one year of unprotected intercourse, the remaining 15 % of couples cannot, resulting in approximately 2.4 million couples diagnosed yearly as infertile in the United States. In 30 % of these infertile couples, a male factor is solely responsible; in 20 %, combined male and female factors are present, indicating a male factor in about half of the cases of infertility.

In this study, sperm that remains after In Vitro Fertilization (IVF) or Intracytoplasmic Injection (ICSI) procedures at Baystate Reproductive Medicine will be studied to determine whether capacitation and or ability to induce Ca 2+ oscillations correlate with the percent fertilization seen in the treatment cycles. Sperm that fertilize <20% of oocytes will be compared with sperm which fertilize >80% of ooctyes. In order to minimize oocyte contribution to the fertilization rate, only cycles in which the female partner is 21-37 years old will be included in the study. Capacitation of sperm used for IVF will be analyzed by testing for tyr phosphorylation and for the progesterone-induced acrosome reaction. The ability of sperm used for ICSI to induce Ca 2+ oscillations will be tested by injecting the discard sperm into mouse oocytes and recording the oscillations which are induced. In addition, the presence of PLC, which has been shown to induce Ca 2+ oscillations, will be analyzed. A long range goal of this study is to develop clinically useful assays for analyzing fertilization failure.

Effective date: September 1, 2005

TILs in high grade breast tumors: role of Notch signaling
Sallie Smith Schneider, Ph.D., Pioneer Valley Life Sciences Institute
Giovanna Crisi, M.D., Pathology, Baystate Medical Center
Lisa Minter, Ph.D., Vet and Animal Sciences, UMass Amherst

Lymphocytes and other immune cells are involved in normal mammary gland development, as well as the pathogenesis to breast cancer. While the immune system is often associated with anticancer activity, immune cells can also enhance the secretion inflammatory cytokines and enzymes which promote invasion and angiogenesis. Many tumor infiltrating immune cells often possess a suppressive capability as well which can shut down the responses of other lymphocytes. The mechanism by which tumor cells subvert immune function to promote the progression to cancer is unknown.

We have found that Notch is expressed at very high levels in many of the immune cells in the peritumoral areas in women with breast cancer. Immune cells near, but outside the tumor, don't express this level of Notch suggesting that the tumor may promote this sustained irregular expression, perhaps through modulation of Notch ligands or fringe proteins. Given the role of deregulated Notch in immune function our hypothesis is that the tumor is able to subjugate the normal immune function through activation of this evolutionarily conserved pathway. The work in this proposal will test this hypothesis by examining the changes in Notch, Notch ligands, and fringe proteins in a mouse model for breast cancer. We will modulate the levels of these proteins and analyze the rate of growth of tumor lines as well as the activity of the population of immune cells.

Effective date: September 1, 2005

Misregulation of Acheron Expression in Human Rhabdomyosarcoma
Lawrence Schwartz, Ph.D., Biology Department, UMass Amherst
James Mueller, M.D., Pathology, Baystate Medical Center

Rhabdomyosarcoma (RMS) constitutes one of the most prevalent childhood soft tissue tumors, accounting for more than 50% of pediatric sarcomas. RMSs are derived from cells of a skeletal muscle-specific lineage at an early point in differentiation. These tumors express the muscle-specific transcription factor MyoD and many have histological similarity to developing fetal skeletal muscle but fail to differentiate. Not surprisingly it has been demonstrated that the metastatic potential of RMS is inversely related to the degree of differentiation. In fact, one key goal in RMS research is to identify factors that can facilitate RMS differentiation into mature skeletal muscle.

We have cloned and characterized a gene that encodes the novel protein Acheron. Acheron acts upstream of MyoD and controls the decision of skeletal muscle cells to differentiate. In preliminary studies we have found that Acheron expression is misregulated in certain forms of RMS in humans. We are testing the hypothesis that defects in Acheron function contribute to the failure of RMS cells to differentiate.

Effective Date: September 1, 2005

Back to top